Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 9, 2011, Pages 986-992

  Alvarez Perez, F J ^a,b   Castelo Branco, M ^a,b   Alvarez Sabin, J ^c  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b Hospital Universitário de Covilhã   (Portugal)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; FIBRINOGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE PHASE RESPONSE; AGE; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; ATHEROTHROMBOTIC STROKE; BRAIN INFARCTION; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL CLASSIFICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; D DIMER FIBRINOGEN RATIO; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LACUNAR INFARC STROKE; LEFT VENTRICULAR AKINESIA; LEFT VENTRICULAR HYPOKINESIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX DIFFERENCE; SMOKING; TACI SYNDROME; TOAST CRITERIA; TOTAL ANTERIOR CAROTID INFARCTION SYNDROME; TRIACYLGLYCEROL BLOOD LEVEL; TRIAL OF ORG 10172 IN ACUTE ISCHAEMIC STROKE CRITERIA;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD SEDIMENTATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; ELECTROCARDIOGRAPHY; EMBOLISM; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; STROKE; THROMBOSIS;

EID: 80051549049     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.230870     Document Type: Article

References (37)

1. Mohr JP, Caplan LR, Melski JW, et al. Harvard Cooperative Stroke Registry: a prospective registry. Neurology 1978;28:754-62. (Pubitemid 8382975)
2. Macko RF, Ameriso SF, Barndt R, et al. Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke 1996;27:1999-2004. (Pubitemid 26372570)
3. Wu T, Trevisan M, Genco RJ, et al. Periodontal disease and risk of cerebrovascular disease: the First National Health and Nutrition Examination Survey and its follow-up study. Arch Intern Med 2000;160:2749-55.
4. Gillum RF, Mussolino ME, Makuc DM. Erythrocyte sedimentation rate and coronary heart disease: the NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol 1995;48:353-61.
5. Chamorro A, Vila N, Ascaso C, et al. Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke 1995;26:573-6.
6. Balestrino M, Partinico D, Finocchi C, et al. White blood cell count and erythrocyte sedimentation rate correlate with outcome in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 1998;7:139-44.
7. Eikelboom JW, Hankey GJ, Baker RI, et al. C-reactive protein in ischemic stroke and its etiologic subtypes. J Stroke Cerebrovasc Dis 2003;12:74-81. (Pubitemid 36506246)
8. Muir KW, Weir CJ, Alwan W, et al. C-reactive protein and outcome after ischemic stroke. Stroke 1999;30:981-5. (Pubitemid 29211614)
9. Turaj W, Slowik A, Dziedzic T, et al. Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. J Neurol Sci 2006;246:13-19. (Pubitemid 43815352)
10. Bots ML, Elwood PC, Salonen JT, et al. Level of fibrinogen and risk of fatal and nonfatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002;56(Suppl 1):i14-18.
11. Rothwell PM, Howard SC, Power DA, et al. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke 2004;35:2300-5. (Pubitemid 39311253)
12. Castellanos M, Castillo J, García MM, et al. Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke 2002;33:982-7. (Pubitemid 34293579)
13. Fassbender K, Bertsch T, Mielke O, et al. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999;30:1647-50. (Pubitemid 29379618)
14. Takano K, Yamaguchi T, Kato H, et al. Activation of coagulation in acute cardioembolic stroke. Stroke 1991;22:12-16.
15. Lip GYH, Lowe GDO, Rumley A, et al. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 1995;73:527-33.
16. Feinberg W, Bruck DC, Ring ME, et al. Hemostatic markers in acute stroke. Stroke 1989;20:592-7. (Pubitemid 19139085)
17. Feinberg W, Erickson LP, Bruck D, et al. Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome. Stroke 1996;27:1296-300. (Pubitemid 26286155)
18. Gordon DL, Bendixen BH, Adams HP Jr, et al. Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology 1993;43:1021-7. (Pubitemid 23150580)
19. Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-7.
20. Koch HJ, Horn M, Bogdahn U, et al. The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. J Stroke Cerebrovasc Dis 2005;14:75-9. (Pubitemid 40332497)
21. Ageno W, Finazzi S, Steidl L, et al. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtype. Arch Intern Med 2002;162:2589-93. (Pubitemid 35453498)
22. Ladenvall C, Jood K, Blomstrand C, et al. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke 2006;37;2018-23. (Pubitemid 44309897)
23. Kucher N, Kohler HP, Dornhöfer T, et al. Accuracy of D-dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study. J Thromb Haemost 2003;1:708-13.
24. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-6.
25. Pittock SJ, Meldrum D, Hardiman O, et al. The Oxfordshire Community Stroke Project classification: correlation with imaging, associated complications, and prediction of outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis 2003;12:1-7. (Pubitemid 36292851)
26. Barber M, Langhorne P, Rumley A, et al. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004;35:1421-5. (Pubitemid 38697469)
27. Mistry P, Chawla KP, Rai HP, et al. Plasma fibrinogen levels in stroke. J Postgrad Med 1990;36:1-4.
28. Van Goor MP, Gomez-Garcia EB, Leebeek FW, et al. The-148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study. J Neurol Neurosurg Psychiatry 2005;76:121-3. (Pubitemid 40013505)
29. Kofoed SC, Wittrup HH, Sillesen H, et al. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J 2003;24:567-76. (Pubitemid 36343103)
30. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
31. Ferreiros ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63. (Pubitemid 29529287)
32. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460-5. (Pubitemid 28273285)
33. Ridker PM, Buring JE, Cook NR, et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy Am women. Circulation 2003;107:391-7.
34. Lip GY, Patel JV, Hughes E, et al. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with non valvular atrial fibrillation. Relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 2007;38:1229-37. (Pubitemid 351664238)
35. Emsley HC, Smith CJ, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol 2003;139:93-101. (Pubitemid 36694395)
36. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, et al; for the German Stroke Registers Study Group. Predictors of in-hospital mortality and attributable risks of death after ischemic stroke. Arch Intern Med 2004;164:1761-8. (Pubitemid 39215645)
37. Elkind MS, Coates K, Tai W, et al. Levels of acute phase proteins remains stable after ischemic stroke. BMC Neurol 2006;6:37-43.